ALERT: Be aware of fraudulent job offers using the Cerium Pharmaceuticals name. More Information.

Board of Directors

Thomas A. DePasquale

Chairman

Serial Entrepreneur, Public Company Executive, Private Investor

  • Several successful startups, including running significant parts of public companies.
  • Brings a different approach to drug development, promoting significantly lower level of investment while enabling a process far ahead of industry norms.
  • Strong focus on Inovationas a path to significant reduction in health care cost.
  • Board Member, University of Virginia
  • Chairman/CEO/Founder, Curb (App)
  • Executive Vice President, Technology, Concur
  • President, CEO and Founder, Outtask
  • Executive Vice President, Platinum Technology
  • Manager, Arthur Anderson

James (Jim) Gale

Board Member

Founding Partner & Managing Director, Signet Healthcare Partners

  • 30 years healthcare investing and finance experience.
  • Managing Director in Signet Fund IV.
  • Currently Chairman of the Board of AlpexPharma, S.A., Knight Therapeutics Inc. (TSX: GUD), Teligent (NSDQ: TLGT, formerly IGI Laboratories)
  • Serves on the Board of Bionpharma Inc., Chr. Olesen Synthesis A/S, CoreRxInc, and Pharmaceutics International (Pii)
  • Prior portfolio company boards include Arbor Pharmaceuticals, AmarinCorporation, eResearchTechnologies Inc., and Valera Pharmaceuticals

Steve Eskenazi

Board Member

Steve has had a long and successful career in angel investing, venture capital, investment banking, and technology, spanning more than 25 years. Steve is currently a member of several angels groups and has amassed a very high-performing angel investing track record.

From 1997-2008, Steve was a Managing Director/Managing General Partner with Walden Venture Capital, where he was responsible for building Walden’s Digital Media and Technology practice, which invested in several successful companies including BlueLithium, Cybertrust, DigitalThink, and Pandora.

Steve joined Walden from Alex. Brown & Sons, where he worked for seven years as a Managing Director and founder of Alex. Brown’s New Media Group. At Alex. Brown, he was directly involved in financing and sponsoring a wide range of media technology companies, including Electronic Arts and America Online. In both 1995 and 1996, Steve was selected by The Wall Street Journal as an All-Star software analyst and stock picker.

Originally from the Bronx and Lido Beach, NY, Steve now lives in the San Francisco Bay Area with his wife, three kids, and dog, Cashew.

Peter Collum

Peter Collum

Board Member

Peter has over 24 years of experience in the biopharma industry, most recently as Chief Financial Officer and Chief Business Officer of Pharnext SA, a public late-stage biotech company focused on combination drug approaches in orphan neurology. Previously, he spent 17 years in healthcare investment banking at both Bank of America and MTS Health Partners, focused on M&A, financing and business development transactions for both public and private life sciences companies in the US and abroad. He started his career in the pharma industry as an engineer at Roche. Peter holds an MBA from the University of Chicago Booth School of Business and a BS from the Rutgers University College of Engineering, and lives in northern New Jersey with his wife and three children.

GREGG LAPOINTE, MBA, CPA

Board Member

ROBERT J. RUBIN, MD

Board Member